Growth Metrics

Nu-Med Plus (NUMD) Profit After Tax Growth (1y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -12.28%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 99.26%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 4.70%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 125.69%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 51.30%
10 Nu-Med Plus - - - -19.55%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -19.55%
Sep 30, 2025 35.93%
Jun 30, 2025 32.52%
Mar 31, 2025 8.67%
Dec 31, 2024 81.35%
Sep 30, 2024 -13.84%
Jun 30, 2024 28.92%
Mar 31, 2024 22.61%
Dec 31, 2023 -232.84%
Sep 30, 2023 71.74%
Jun 30, 2023 58.12%
Mar 31, 2023 50.22%
Dec 31, 2022 137.93%
Sep 30, 2022 50.96%
Jun 30, 2022 76.06%
Mar 31, 2022 84.12%
Dec 31, 2021 77.23%
Sep 30, 2021 73.92%
Jun 30, 2021 73.30%
Mar 31, 2021 -132.66%
Dec 31, 2020 -135.09%
Sep 30, 2020 -201.39%
Jun 30, 2020 -266.05%
Mar 31, 2020 64.19%
Dec 31, 2019 38.45%
Sep 30, 2019 71.42%
Jun 30, 2019 -43.00%
Mar 31, 2019 -190.33%
Dec 31, 2018 -123.40%
Sep 30, 2018 -268.48%
Jun 30, 2018 -49.55%
Mar 31, 2018 -103.70%
Dec 31, 2017 52.23%
Sep 30, 2017 81.48%
Jun 30, 2017 49.11%
Mar 31, 2017 -63.65%
Dec 31, 2016 96.04%
Sep 30, 2016 -151.21%
Jun 30, 2016 42.02%
Mar 31, 2016 9,050.20%
Dec 31, 2015 -1,409.84%
Sep 30, 2015 -26.52%
Jun 30, 2015 -94.42%
Mar 31, 2015 42.61%
Sep 30, 2014 -70.98%
Jun 30, 2014 -451.51%
Mar 31, 2014 -158.44%
Sep 30, 2013 -28.34%
Jun 30, 2013 20.69%
Mar 31, 2013 -323.15%